At a glance
ClinicalIndex Comparison RecordN/ACompleted· 200 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CoreValve Advance-II Study: Best Practices Investigation of Patients Implanted With the Medtronic CoreValve Bioprosthesis.
In Brief
An observational study for Aortic Valve Stenosis and Valvular Heart Disease. Completed, enrolled 200 participants across 9 sites in 6 countries.
Detailed Summary
The CoreValve ADVANCE-II Study is a best practices investigation of patients implanted with the Medtronic CoreValve bioprosthesis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Valve Stenosis, Valvular Heart Disease
CountriesBelgium, Czechia, Germany, Italy, Netherlands, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2011
First PostedJun 2012
Primary CompletionOct 2013
Study CompletionMar 2014
TodayJul 2026
First PostedJun 21, 2012
Enrollment StartOct 1, 2011
Primary CompletionOct 1, 2013
Study CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 14.0 years ago